XBiotech Inc.
XBIT
$2.27
-$0.04-1.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.40M | 967.00K | 1.00M | 1.93M | 927.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.76M | 6.05M | 6.34M | 13.55M | 8.75M |
| Operating Income | -29.76M | -6.05M | -6.34M | -13.55M | -8.75M |
| Income Before Tax | -26.82M | -5.91M | -1.73M | -10.86M | -10.55M |
| Income Tax Expenses | 76.00K | 102.00K | 28.00K | 29.00K | -41.00K |
| Earnings from Continuing Operations | -26.89M | -6.01M | -1.76M | -10.88M | -10.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.89M | -6.01M | -1.76M | -10.88M | -10.51M |
| EBIT | -29.76M | -6.05M | -6.34M | -13.55M | -8.75M |
| EBITDA | -29.38M | -5.62M | -5.90M | -13.11M | -8.31M |
| EPS Basic | -0.88 | -0.20 | -0.06 | -0.36 | -0.34 |
| Normalized Basic EPS | -0.56 | -0.12 | -0.04 | -0.22 | -0.22 |
| EPS Diluted | -0.88 | -0.20 | -0.06 | -0.36 | -0.34 |
| Normalized Diluted EPS | -0.56 | -0.12 | -0.04 | -0.22 | -0.22 |
| Average Basic Shares Outstanding | 30.49M | 30.49M | 30.49M | 30.49M | 30.47M |
| Average Diluted Shares Outstanding | 30.49M | 30.49M | 30.49M | 30.49M | 30.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |